#INMB

StockTitan

@stocktitan.net

1 month ago

INmune Bio Inc Issues Shareholder Letter Reviewing 2025 Milestones and Outlining 2026 Strategic Initiatives INmune Bio (NASDAQ: INMB) CEO David Moss reviewed 2025 progress and outlined 2026 priorities, highlighting clinical and regulatory milestones for two lead programs: CORDStrom for recessive dystrophic epidermolysis bullosa (RDEB) and XPro (XPro1595) for Alzheimer’s disease. Key 2025 items include three commercial pilot-scale manufacturing runs for CORDStrom, a planned MAA submission in mid‑summer 2026 to the UK MHRA and a targeted BLA submission late 2026 to FDA (timelines subject to regulatory feedback). XPro’s Phase 2 MINDFuL showed biomarker‑defined signals (EMACC effect size 0.27) guiding a precision‑medicine registrational path. Cash and equivalents were approximately $27.7M as of Sept 30, 2025, with financing and rebates expected to fund operations through year‑end 2026.

#INMB INmune Bio Inc Issues Shareholder Letter Reviewing 2025 Milestones and Outlining 2026 Strategic Initiatives

www.stocktitan.net/news/INMB/i-nmune-bio-in...

StockTitan

@stocktitan.net

3 months ago

Peer Reviewed Study Highlights Therapeutic Potential Around Application of Stromal Cell Therapies Such as INmune Bio’s CORDStrom™ Platform INmune Bio (NASDAQ: INMB) announced a peer-reviewed overview on mesenchymal stromal cell (MSC) therapies published in Cytotherapy, titled “Fate and Function of Exogenously Administered MSCs: Current Insights and Future Directions.”Lead scientist on INmune’s CORDStrom™ R&D, Dr Nikita M. Patel, was one of the senior authors on an invitation-only working party that reviewed current knowledge and gaps for MSC development. Topics included systemic delivery, local/depot delivery (the CORDStrom™ approach), and in vivo persistence. The company said it is initially developing CORDStrom™ for RDEB and expects to file a BLA and MAA in 2026.

#INMB Peer Reviewed Study Highlights Therapeutic Potential Around Application of Stromal Cell Therapies Such as INmune Bio’s CORDStrom™ Platform

www.stocktitan.net/news/INMB/peer-reviewed-...

StockTitan

@stocktitan.net

3 months ago

#INMB INmune Bio Reports New Phase 2 Grey Matter Imaging Data at CTAD Conference Reinforcing XPro1595’s Evidence Base in High-Inflammation Alzheimer's Patients

www.stocktitan.net/news/INMB/i-nmune-bio-re...

StockTitan

@stocktitan.net

3 months ago

#INMB INmune Bio Announces Two Presentations at the Upcoming 18th Annual CTAD Conference

www.stocktitan.net/news/INMB/i-nmune-bio-an...

StockTitan

@stocktitan.net

4 months ago

INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company focused on developing treatments that harness the patient’s innate immune system

#INMB INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update

www.stocktitan.net/news/INMB/i-nmune-bio-in...

Small Cap Strategist

@smcapstrategist.bsky.social

7 months ago

Most searched small-cap stocks, Mon Aug 4th - #INMB #FFAI #SRPT #VERB #NVTS #ONDS #SNGX #DNN #PBM #AEO #TLRY #SFIX #SBET #PLUG #OPEN #COMM #CMPS #REPL #BLDE - More: crystalequityresearch.com/most-searche... - #smallcap

StockTitan

@stocktitan.net

7 months ago

INmune Bio's Novel NK Cell Therapy Shows Tumor Reduction in Advanced Prostate Cancer Trial New cancer therapy demonstrates safety and NK cell activation in over 50% of advanced prostate cancer patients, with some showing complete tumor elimination. See full data.

#INMB INmune Bio’s CaRe PC Trial of INKmune™ in Metastatic Castration-Resistant Prostate Cancer Meets Endpoints and Is Closed to Enrollment

www.stocktitan.net/news/INMB/i-nmune-bio-s-...

StockTitan

@stocktitan.net

7 months ago

INmune Bio to Publish Video Detailing MINDFuL Trial Findings of XPro™ Presented at the Alzheimer’s Association International Conference INmune Bio (NASDAQ: INMB) announced plans to release a video detailing additional findings from their Phase 2 MINDFuL trial of XPro™, their selective soluble TNF inhibitor for Alzheimer's disease. The video will follow their presentation at the Alzheimer's Association International Conference (AAIC) in Toronto.The trial demonstrated that XPro™ showed consistent benefits after 6 months in patients with amyloid-beta pathology and specific inflammatory biomarkers. Dr. Sharon Cohen will present the data at AAIC on July 29, 2025, from 2:00 to 3:30 PM ET, with the detailed video becoming available on July 31, 2025, at 4 PM ET on INmune Bio's YouTube channel.

#INMB INmune Bio to Publish Video Detailing MINDFuL Trial Findings of XPro™ Presented at the Alzheimer’s Association International Conference

www.stocktitan.net/news/INMB/i-nmune-bio-to...

Market Wire News

@marketwirenews.com

8 months ago

JUST IN: ( NASDAQ: #INMB ) INmune Bio Reports Key Findings from Phase 2 MINDFuL Trial of XPro(TM) in Early Alzheimer's Disease

InsiderFinance

@insiderfinance.com

8 months ago

🎯 Sweep Options Activity trade ideas! Institutions trading #options urgently with strong consensus

🎯 Sweep Options Activity trade ideas! Institutions trading #options urgently with strong consensus on direction.

AM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#META, #AAPL, #SOUN, #INMB, #AVGO

#OptionFlow #OptionsTrading #Trading

StockTitan

@stocktitan.net

8 months ago

INmune Bio Reports Key Findings from Phase 2 MINDFuL Trial of XPro™ in Early Alzheimer’s Disease INmune Bio (NASDAQ: INMB) has reported results from its Phase 2 MINDFuL trial evaluating XPro™, a selective soluble TNF inhibitor, in early Alzheimer's Disease (AD). While the modified intent-to-treat population (n=200) did not meet the primary cognitive endpoint, a predefined subgroup of amyloid-positive early AD patients with two or more biomarkers of inflammation (n=100) showed positive results.Key findings in the subgroup demonstrated: Clinical benefit on the primary endpoint EMACC (effect size: 0.27)Improvement on the Neuropsychiatric Inventory (effect size: -0.24)Biological benefit in blood levels of pTau217 (effect size: -0.20)The treatment was well-tolerated with no occurrences of ARIA-E or ARIA-H, even in high-risk ApoE4+/+ patients. The most common adverse events were injection site reactions, affecting 80% of the XPro™ group. The company plans to file for Breakthrough Therapy Designation with the FDA and schedule an End-of-Phase 2 meeting in Q4 2025 to define the path for a pivotal trial.

#INMB INmune Bio Reports Key Findings from Phase 2 MINDFuL Trial of XPro™ in Early Alzheimer’s Disease

www.stocktitan.net/news/INMB/i-nmune-bio-re...

InsiderFinance

@insiderfinance.com

8 months ago

🚨 Institutions #optionsvolume surge detected! PM Top Momentum Activity from 🔥 INSIDERFINANCE.COM

🚨 Institutions #optionsvolume surge detected!

PM Top Momentum Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #INMB 6.7x
2. #GRAB 5.7x
3. #NKE 5.5x
4. #SNAP 5.3x
5. #VIAV 5.2x

#OptionFlow #OptionsTrading #Trading

InsiderFinance

@insiderfinance.com

8 months ago

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily averag

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily average with strong consensus on direction.

AM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#NE, #SNAP, #INMB, #TMUS, #NPWR

#OptionFlow #OptionsTrading #Trading

InsiderFinance

@insiderfinance.com

8 months ago

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expir

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expirations.

AM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#RILY, #HOOD, #DDD, #BBAI, #INMB

#OptionFlow #OptionsTrading #Trading

PRISM MarketView

@prismmarketview.bsky.social

8 months ago

PRISM Mid-Day Movers: Robotic Medical Innovation and Disappointing Earnings Diverge Indices
#NanoVibronix Inc. ( #NAOV)
#AethlonMedical Inc. ( #AEMD)
#INmuneBio, Inc. ( #INMB)
#HeliusMedicalTechnologies, Inc. ( #HSDT)
#AdialPharmaceuticals, Inc. ( #ADIL)

prismmarketview.com/prism-mid-da...

InsiderFinance

@insiderfinance.com

8 months ago

🚨 Institutions #optionsvolume surge detected! AM Top Momentum Activity from 🔥 INSIDERFINANCE.COM

🚨 Institutions #optionsvolume surge detected!

AM Top Momentum Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #NE 3.0x
2. #NKE 3.0x
3. #SNAP 2.8x
4. #INMB 2.3x
5. #TMUS 2.2x

#OptionFlow #OptionsTrading #Trading

StockTitan

@stocktitan.net

8 months ago

INmune Bio, Inc. Announces Approximately $19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules INmune Bio (NASDAQ: INMB), a clinical-stage inflammation and immunology company, has announced a registered direct offering of 3,000,000 shares of common stock priced at $6.30 per share. The offering, expected to close around June 30, 2025, aims to raise approximately $19 million in gross proceeds.The offering is priced at-the-market under Nasdaq rules, with A.G.P./Alliance Global Partners serving as the sole placement agent. The company plans to use the net proceeds for working capital and general corporate purposes. The offering is being made through an effective shelf registration statement previously filed with the SEC.

#INMB INmune Bio, Inc. Announces Approximately $19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

www.stocktitan.net/news/INMB/i-nmune-bio-in...

HumanAlgoHybrid

@humanalgohybrid.bsky.social

8 months ago

INMB up 75%! and other Top after-hours breakouts in stocks for Thursday, June 26, 2025 sorted by range are $INMB $11 (75%), $MRC $15 (13%), $SOGP $4.62 (3%), $MMA $1.5 (35%) #INMB #chartanalysis #gappers #daytrading

StockTitan

@stocktitan.net

8 months ago

Major Alzheimer's Treatment Milestone: INmune Bio Reveals Phase 2 Trial Results Next Week Join INmune Bio's conference call on June 30 for crucial Phase 2 MINDFuL trial data in early Alzheimer's treatment. Get exclusive insights into the results.

#INMB INmune Bio Inc. to Announce Top Line Results from MINDFuL Phase 2 Trial in Early Alzheimer’s on Monday, June 30th

www.stocktitan.net/news/INMB/i-nmune-bio-in...

InsiderFinance

@insiderfinance.com

8 months ago

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expir

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expirations.

PM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#INMB, #WOLF, #GME, #TMC, #ALT

#OptionFlow #OptionsTrading #Trading

InsiderFinance

@insiderfinance.com

8 months ago

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations! PM Top Unusual

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations!

PM Top Unusual Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #UPXI 92% OTM
2. #INMB 61% OTM
3. #WOLF 49% OTM
4. #GME 34% OTM
5. #TMC 32% OTM

#OptionFlow #OptionsTrading #Trading

InsiderFinance

@insiderfinance.com

8 months ago

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expir

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expirations.

AM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#INMB, #WOLF, #GME, #CVNA, #CRCL

#OptionFlow #OptionsTrading #Trading

InsiderFinance

@insiderfinance.com

8 months ago

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations! AM Top Unusual

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations!

AM Top Unusual Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #INMB 63% OTM
2. #WOLF 49% OTM
3. #GME 34% OTM
4. #CVNA 32% OTM
5. #CRCL 27% OTM

#OptionFlow #OptionsTrading #Trading

InsiderFinance

@insiderfinance.com

8 months ago

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations! Weekly Top Unu

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations!

Weekly Top Unusual Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #NA 83% OTM
2. #NNE 80% OTM
3. #INMB 67% OTM
4. #SMR 63% OTM
5. #MSTR 61% OTM

#OptionFlow #OptionsTrading #Trading

InsiderFinance

@insiderfinance.com

8 months ago

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expir

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expirations.

PM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#INMB, #ALT, #WOLF, #AIP, #RCAT

#OptionFlow #OptionsTrading #Trading

InsiderFinance

@insiderfinance.com

8 months ago

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations! PM Top Unusual

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations!

PM Top Unusual Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #INMB 66% OTM
2. #ALT 63% OTM
3. #WOLF 53% OTM
4. #SMR 52% OTM
5. #DJT 45% OTM

#OptionFlow #OptionsTrading #Trading

InsiderFinance

@insiderfinance.com

8 months ago

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expir

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expirations.

PM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#INMB, #VG, #CVNA, #BULL, #NEE

#OptionFlow #OptionsTrading #Trading

InsiderFinance

@insiderfinance.com

8 months ago

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations! PM Top Unusual

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations!

PM Top Unusual Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #NNE 80% OTM
2. #INMB 68% OTM
3. #VG 48% OTM
4. #APPS 44% OTM
5. #TSM 29% OTM

#OptionFlow #OptionsTrading #Trading

InsiderFinance

@insiderfinance.com

8 months ago

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expir

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expirations.

AM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#NNE, #INMB, #PLTR, #GME, #BULL

#OptionFlow #OptionsTrading #Trading

InsiderFinance

@insiderfinance.com

8 months ago

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations! AM Top Unusual

🚀 Institutions taking big swings on #UnusualOptionsActivity with short expirations!

AM Top Unusual Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #NNE 80% OTM
2. #INMB 68% OTM
3. #PLTR 29% OTM
4. #ALT 29% OTM
5. #CRCL 27% OTM

#OptionFlow #OptionsTrading #Trading